|
ABBV-706 Clinical Trials
2 actively recruiting trials across 2 locations
▲ +1 trial since July 2026
Pipeline
Phase 2: 1Phase 3: 1
Top Sponsors
- AbbVie2
Indications
- Small Cell Lung Cancer2
- Lung Cancer2
- Cancer2
Birmingham, Alabama1 trial
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Birmingham Hematology and Oncology Associates d/b/a Alabama Oncology /ID# 280063
Phase 3
New Haven, Connecticut1 trial
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
Yale University School of Medicine /ID# 278181
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.